WSG-ARA_3 | R Documentation |
Kaplan-Meier digitized data from WSG-ARA, figure 3 (PMID 24356620). A reported sample size of 1,234 for a primary endpoint of EFS in breast cancer.
`WSG-ARA_3`
A data frame of 1,170 observations and 3 variables:
time | event time (in months) | |
event | EFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (da_negative, da_positive) | |
Nitz U, Gluz O, Zuna I, et al. Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer. Ann Oncol 2014; 25: 75–80.
summary(`WSG-ARA_3`)
kmplot(`WSG-ARA_3`)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.